Who owns LEXARIA BIOSCIENCE?

Tip: Access positions for across all investors

Analyze quarterly positions in Lexaria Bioscience with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Lexaria Bioscience stock

Who bought or sold LEXARIA BIOSCIENCE this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Invenomic Capital Management 477k $455k -5% Sep 2025
 View chart
Murchinson 420k $400k 100% Sep 2025
 View chart
UBS Group 361k $223k 4996% Dec 2025
 View chart
Vanguard Group 259k $160k 0% Dec 2025
 View chart
Geode Capital Management 175k $167k 0% Sep 2025
 View chart
Toronto-Dominion Bank 140k $840k 5% Sep 2025
 View chart
Byrne Asset Management 106k $65k 237% Dec 2025
 View chart
State Street Corporation 39k $37k 0% Sep 2025
 View chart
Virtu Financial 29k $28k 100% Sep 2025
 View chart
BlackRock 27k $26k 0% Sep 2025
 View chart
Krilogy Financial 20k $16k 0% Dec 2025
 View chart
Northern Trust 18k $18k 0% Sep 2025
 View chart
Renaissance Technologies 10k $9.6k 100% Sep 2025
 View chart
Royal Bank of Canada 7.3k $7.0k 0% Sep 2025
 View chart
Tower Research Capital 3.6k $3.5k 84% Sep 2025
 View chart
Advisor Group Holdings 2.2k $2.1k 0% Sep 2025
 View chart
Federation des caisses Desjardins du Quebec 382.00 $361.983200 0% Sep 2025
 View chart
Rockefeller Capital Management 200.00 $191.000000 100% Sep 2025
 View chart
Farther Finance Advisors 166.00 $102.007000 0% Dec 2025
 View chart
Gables Capital Management 13.00 $12.000300 0% Sep 2025
 View chart
Pnc Financial Services 6.00 $6.000000 100% Sep 2025
 View chart

Who sold out of Lexaria Bioscience?

Fund or Company Name Date Sold Shares Held Valued At
Sabby Management Jun 2025 1.2M $1.0M
Wealth Enhancement Advisory Services Sep 2025 36k $30k
Oakworth Capital Jun 2025 5.0k $4.4k
Wells Fargo & Company Jun 2025 2.0k $1.7k